Where do stem cells come from? One source of stem cells that has risen to the forefront of the stem cell therapy industry in recent years is the umbilical cord derived mesenchymal stem cell. These cells are found in the Wharton’s Jelly that surrounds the umbilical cord. Umbilical cord-derived mesenchymal stem cells (UC-MSCs) are readily accessible, can be easily obtained without invasive procedures, and are considered to be a successful alternative to bone marrow or adipose-derived MSCs. Furthermore, UC-MSCs are believed to be a more potent source of MSCs due to their higher proliferation and differentiation capacity compared to bone marrow-derived MSCs.
Why Can’t I Get This Type of Stem Cell Therapy In The United States?
Regulations in the United States restrict the manner in which umbilical derived stem cells can be used in treatment. These restrictions mean that the average treatment in the U.S. does not exceed 1 to 3 million cells and these cells are delivered to the treatment center frozen. There is no reasonable way to determine how many of these cells are reanimated or “live” at time of treatment.
I’ve Heard That You Can Get Stem Cell Therapy In The U.S.
There has been a recent surge in practices throughout the U.S. performing IV treatments with stem cells derived from adipose tissue. Adipose is your bodies fat tissue. It is also a prime area that our bodies use to store toxins.
The cells derived from adipose are the age of the patient, meaning they are missing the healing benefits of young, umbilical derived mesenchymal stem cells.
If they had tremendous healing power, you would not have developed the condition you are suffering with currently as those cells have been in your body for years.
We feel as if the type of tissue makes this treatment unsafe and question the legality of administering any IV stem cell treatment in the United States.
Another type of stem cell used in the U.S. is bone marrow aspirate. These cells are harvested by drilling a hole in your hip or femur, taping a tube into the wound, and extracting bone marrow.
We feel as if there are several reasons that these treatments are less successful than utilizing umbilical derived cells. First, the cells are the age of the patient and suffer from stem cell exhaustion. The older we get the fewer stem cells we have and the less potent they are. Second, the harvesting of the cells is traumatic. Stem cells “home in” on the area that the body needs them most and many of the cells would “home in” on the area of the fresh wound.
Why Should I Travel To Costa Rica For Treatment?
In most developed countries, including Costa Rica, the governments are not beholden to the pharmaceutical industry and are more progressive regarding stem cell therapy treatments. In fact, the U.S. is one of the last developed nations to approve these treatments. In Costa Rica, we are able to allow the cells to follow their natural path of proliferation (multiplication) and therefore, treat our patients with a much higher dose than is legally allowable in the U.S. The stem cells used in our treatments have not been frozen and the cell count ranges from 50 million to 300 million cells. Higher doses of cells that are live and never frozen account for substantially better patient outcomes.
We may be the only stem cell therapy lab in the World that conducts DNA testing as well as genetic testing on all tissue that we use in treatment. One of the MDs on our team is also a geneticist.
Mesenchymal stem cells are a type of stem cell that can differentiate into various cell types, such as osteocytes, chondrocytes, and adipocytes. MSCs have been extensively studied for their therapeutic applications in regenerative medicine due to their ability to modulate the immune system, promote tissue repair and regeneration, and reduce inflammation.
Are There Studies To Support These Claims?
Studies have shown that UC-MSCs are effective in treating a wide range of conditions, including cardiovascular disease, neurological disorders, and autoimmune diseases.
For example, in a clinical trial involving patients with acute myocardial infarction (AMI), UC-MSC treatment resulted in improved left ventricular function and reduced infarct size compared to the control group.
In another study, UC-MSCs were shown to improve neurological function in patients with spinal cord injury, with some patients reporting improved sensation and mobility.
Additionally, UC-MSCs have also been shown to have anti-inflammatory and immunomodulatory effects, making them a promising treatment for autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis. In preclinical studies, UC-MSC treatment has been shown to reduce inflammation, improve symptoms, and preserve joint structure in animal models of rheumatoid arthritis.
Are These Stem Cells Safe?
Mesenchymal stem cells derived from the Wharton’s Jelly that surrounds the umbilical cord, they show no risk of immune rejection and tumorigenesis compared to other types of stem cells.
This is because they are obtained from the umbilical cord, which is an immune-privileged site, and they have a low expression of histocompatibility antigens, and have been reported to have no likelihood of immune rejection.
Furthermore, UC-MSCs have also been shown to be negative for markers associated with malignancy, such as CD34 and CD45, meaning they are not known to cause or increase the size of tumors.
Can Stem Cells Cause Cancer?
In the earliest renditions of stem cell therapy, embryonic and fetal cells were used in treatment. Like most industries, tremendous improvements develop over time and embryonic and fetal cells are not legal to use in any of the countries that we operate. It’s important to note that we do not use embryonic or fetal stem cells. Embryonic stem cells have been a subject of intense research in recent years due to their potential to develop into various types of cells and tissues, making them a dangerous, immoral, unethical, and illegal resource for medical applications. There are significant concerns about the dangers of using embryonic stem cells, in addition to ethical considerations, they present the potential for the development of tumors.
One of the primary ethical concerns surrounding the use of embryonic stem cells is that they are derived from human embryos, which are destroyed in the process. This has sparked a considerable debate about the moral implications of using human embryos for scientific research, particularly in the context of embryonic stem cell research.
The potential risks associated with the use of embryonic stem cells in medical treatments are also significant. One of the most significant risks is the potential for the development of tumors. Embryonic stem cells can develop into any type of cell or tissue. They may also develop into cancerous cells if they are not properly controlled or regulated. This is a significant concern for researchers working on embryonic stem cell therapies, as it could potentially lead to the development of cancer in patients receiving these treatments.